The aim of cell-based therapy, in the context of MD, is to introduce dystrophin-expressing cells derived either from healthy precursor cells or from genetically modified patients’ cells, which are capable of tissue integration and repopulation of injured muscles with functional cells. Here, DMD is linked to Menkes disease.